David Vanderstraeten advises and represents Belgian and foreign companies on all aspects of corporate law, with a focus on M&A, private equity, and venture capital transactions. He also advises clients on corporate restructurings and reorganizations and corporate governance.
Recent key representations include the acquisition of HistoGeneX and Caprion Biosciences by Arsenal Capital Partners, the Series B financing rounds of Cowboy SA and Proxyclick SA, and HRH Prince Abdullah's acquisition of Belgian football club Beerschot.
David recently advised other major companies including Cardinal Health, Hexagon, JF Lehman, Mitsui Chemicals, PolyOne, and Riverside.
Experience
- The London School of Economics and Political Science (LL.M. 2015); University of Ghent (J.D. magna cum laude 2014); University of Santa Clara (U.S. exchange program, 2012)
- Brussels Bar
- Dutch, English, and French
We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.
Before sending, please note:
Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.